Gastrointestinal complications of cancer treatment in childhood

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access


Gastrointestinal and liver toxicity are ones of the complications of combined modality treatment for malignant tumors in childhood. Issues of gastrointestinal complications after radiation therapy and chemotherapy are considered in article. We describe the clinical presentation, diagnosis and treatment of diseases and syndromes associated with the effects of the specific treatment. Among infectious complications accented reader's attention to such serious complication such as cryptosporidiosis, cytomegalovirus infection, and viral hepatitis B and C. Described in detail the clinical pattern of cytomegalovirus hepatitis and enterocolitis. The most common effects of abdominal irradiation are post-radiation enteritis and venoocclusive disease, the occurrence of which is associated with concomitant use of cytotoxic drugs and radiation the liver. Often the development of hepatotoxicity is associated with high-dose chemotherapy with allogeneic or autologous stem cell transplantation, as well as prolonged use of methotrexate in patients with acute lymphoblastic leukemia at the stage of maintenance therapy. The article describes the phase drug metabolism in the liver and pathogenesis of disorders. This article lists the chemotherapy agents, the use of which in the schemes of chemotherapy can induce the development of hepatocellular toxicity. Recommendations for dispensary observation and examination of patients with identified disorders of the gastrointestinal and hepato-biliary system.

Full Text

Restricted Access

About the authors

Svetlana Viacheslavovna Ivanova

N. N. Petrov Oncology Research Institute

Department of Children`s Chemotherapy and Combined Modality Therapy

Svetlana Aleksandrovna Kulyova

N. N. Petrov Oncology Research Institute

MD, PhD, Dr Med Sci, Professor, Head. Department of Children`s Chemotherapy and Combined Modality Therapy

Elvira Dzhangirovna Gumbatova

N. N. Petrov Oncology Research Institute

Resident doctor. Department of Children`s Chemotherapy and Combined Modality Therapy

Margarita Borisovna Belogurova

St. Petersburg State Pediatric Medical University

MD, PhD, Dr Med Sci, Professor, Head. Department of Oncology, Pediatric oncology and Radiation therapy


  1. Barnard J. A., Marshall G. S., Neblett W. W. Noncirrhotic portal fibrosis after Wilms’ tumor therapy. Gastroenterol. 1986; 90: 1054-6.
  2. Barrett J. S., Patel D., Dombrowsky E. Risk Assessment of Drug Interaction Potential and Concomitant Dosing Pattern on Targeted Toxicities in Pediatric Cancer Patients. AAPS J. 2013; 15: 775-86.
  3. Bottiglieri T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule. Am. J. Clin. Nutr. 2002; 76: 1151-7.
  4. DeLeve L. D., Shulman H. M., McDonald G. B. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 2002; 22: 27-41.
  5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 2009; 51: 237-67.
  6. Feld J. J., Modi A. A., El-Diwany R. S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenter. 2011; 140: 830-9.
  7. Friedel H. A., Goa K. L., Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs. 1989; 38: 389-416.
  8. Halonen P., Mattila J., Mäkipernaa A. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia. Pediatr. Blood Cancer. 2006; 46: 762-6.
  9. Harb A. H., Abou Fadel C., Sharara A. I. Radiation enteritis. Curr. Gastroenterol. rep. 2014; 16: 383.
  10. Jirtle R. L., Anscher M. S., Alati T. Radiation sensitivity of the liver Adv. Radiat. Biol. 1990; 14: 269-311.
  11. Locasciulli A., Testa M., Valsecchi M. G. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood. 1997; 90: 3799-805.
  12. Maor Y, Malnick S. Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy. Intern. J. Hepatol. 2013; 815105.
  13. McIntosh S., Davidson D. L., O’Brien R. T. Methotrexate hepatotoxicity in children with leukemia. J. Pediatr. 1977; 90: 1019-21.
  14. Perry M. Chemotherapeutic agents and hepatotoxicity. Semin. Oncol. 1992; 19: 551-65.
  15. Rubenstein E. B. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004; 100: 2026-46.
  16. Socie G., Stone J. V., Wingard J. R. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N. Engl. J. Med. 1999; 341: 14-21.



Abstract - 1315

PDF (Russian) - 353


Article Metrics

Metrics Loading ...



Copyright (c) 2015 Ivanova S.V., Kulyova S.A., Gumbatova E.D., Belogurova M.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies